Skip to content

Clinical trials

Observational Respiratory Distress Syndrome trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Distress Syndrome Phase: Observational Country / region: Spain Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20081
20101
20111
20131
20142
20152
20208
20211
20223
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Unknown status5
Recruiting3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospital Universitario de Gran Canaria Doctor Negrín4
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Complejo Hospitalario Universitario de Albacete1
Consorcio Centro de Investigación Biomédica en Red (CIBER)1
Corporacion Parc Tauli1
CytoSorbents, Inc1
European Society of Anaesthesiology1
Fundación para la Investigación Biosanitaria del Principado de Asturias1
Hospital San Carlos, Madrid1
Hospital Sant Joan de Deu1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Distress Syndrome25
COVID-196
Acute Lung Injury5
Pneumonia3
Respiratory Insufficiency3
Cytokine Release Syndrome2
Pulmonary Atelectasis2
Shock, Cardiogenic2
Shock, Septic2
Acute-On-Chronic Liver Failure1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.